JAK Inhibitors for Vitiligo: More Skin Response Over Time JAK Inhibitors for Vitiligo: More Skin Response Over Time

Two JAK inhibitors for non-segmental vitiligo showed better skin clearance in phase 2b trial extensions — ritlecitinib plus twice-weekly doses of UVB light and upadacitinib.Medscape Medical News

Source: Medscape Dermatology Headlines - April 2, 2024 Category: Dermatology Tags: Dermatology Source Type: news